Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Efficacy of a Robotic-assisted Gait Training in Addition to a Conventional Physical Therapy in Parkinson's Disease

NCT02164162 · Habilita, Ospedale di Sarnico · Updated 23 June 2014

What is being tested
Lokomat (Hocoma, Zurich, Switzerland); Conventional physical treatment
For
Parkinson's Disease
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 50 years to 80 years. About 40 people. The full rules are on the registry page.
Where
Italy
When
Starts or started June 2014, ends July 2014. Registered 16 June 2014.
Results
None posted yet.

In the researchers' words

In Parkinson's disease, gait disturbances represent one of the most disabling motor symptoms, frequently associated with an increased risk of falls, loss of independence and a negative impact on quality of life. In recent years, the interest in automated robotic devices for gait training for Parkinson's Disease patients has grown. With their consistent, symmetrical lower-limb trajectories, robotic devices provide many of the proprioceptive inputs that may increase cortical activation and improve motor function while minimizing the intervention of a therapist. So the main aim of this study will be to analyze, through a clinical and an instrumental evaluation, the effectiveness of a Lokomat gait training in subjects affected by Parkinson's disease in comparison to a ground conventional gait training.
ClinicalTrials.gov, NCT02164162

Sites

  • Casa di Cura HabilitaCiserano, Bergamo, Italy